Ronald A. Janis

3.8k total citations · 1 hit paper
57 papers, 3.1k citations indexed

About

Ronald A. Janis is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ronald A. Janis has authored 57 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ronald A. Janis's work include Ion channel regulation and function (27 papers), Neuroscience and Neuropharmacology Research (14 papers) and Cardiac electrophysiology and arrhythmias (12 papers). Ronald A. Janis is often cited by papers focused on Ion channel regulation and function (27 papers), Neuroscience and Neuropharmacology Research (14 papers) and Cardiac electrophysiology and arrhythmias (12 papers). Ronald A. Janis collaborates with scholars based in United States, Canada and Italy. Ronald A. Janis's co-authors include David J. Triggle, D. J. Triggle, Alexander Scriabine, Gordon T. Bolger, David A. Langs, E. E. Daniel, E. Luchowski, J. George Sarmiento, Peter J. Gengo and Paul J. Silver and has published in prestigious journals such as Nature, Circulation Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Ronald A. Janis

56 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New developments in calcium ion channel antagonists

1983 447 citations Ronald A. Janis, D. J. Triggle profile →

Peers

Countries citing papers authored by Ronald A. Janis

Since Specialization

Citations

This map shows the geographic impact of Ronald A. Janis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald A. Janis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald A. Janis more than expected).

Fields of papers citing papers by Ronald A. Janis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald A. Janis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald A. Janis. The network helps show where Ronald A. Janis may publish in the future.

Co-authorship network of co-authors of Ronald A. Janis

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald A. Janis. A scholar is included among the top collaborators of Ronald A. Janis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald A. Janis. Ronald A. Janis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Collaborating with Alexander Scriabine and the Miles Institute for Preclinical Pharmacology 2015 ·Biochemical Pharmacology ·Ronald A. Janis	4
2	High Affinity Binding of a Potassium Channel Agonist to Intact Rat Insulinoma Cells 1993 ·Biochemical and Biophysical Research Communications ·Frederick J. Hoffman, (unknown), (unknown), U. Pleiß, Alexander Scriabine, Ronald A. Janis	9
3	Effects of calcium channel antagonists on the phosphorylation of major protein kinase C substrates in the rat hippocampus 1993 ·Biochemical Pharmacology ·Frederick J. Hoffman, Ronald A. Janis	7
4	ATP‐sensitive K⁺ channels: Pharmacologic properties, regulation, and therapeutic potential 1993 ·Drug Development Research ·Murali Gopalakrishnan, Ronald A. Janis, David J. Triggle	71
5	Effects of Nisoldipine Upon Vasoconstrictor Responses and Binding of Endothelin-1 in Ischemic and Reperfused Rat Hearts 1992 ·Journal of Cardiovascular Pharmacology ·(unknown), (unknown), David E. Johnson, Ronald A. Janis	16
6	Characterization of binding of the ATP-sensitive potassium channel ligand, [3H]glyburide, to neuronal and muscle preparations. 1991 ·Journal of Pharmacology and Experimental Therapeutics ·Murali Gopalakrishnan, D. E. Johnson, Ronald A. Janis, David J. Triggle	70
7	Ca²⁺ channel ligands: Structure‐function relationships of the 1,4‐dihydropyridines 1989 ·Medicinal Research Reviews ·David J. Triggle, David A. Langs, Ronald A. Janis	224
8	Isolation and characterization of a fraction from brain that inhibits 1,4‐[³H]dihydropyridine binding and L‐type calcium channel current 1988 ·FEBS Letters ·Ronald A. Janis, Alka Shrikhande, D. E. Johnson, R. T. McCarthy, Andrew Howard, (unknown), Alexander Scriabine	14
9	Drug action and cellular calcium regulation 1987 ·Ronald A. Janis, Paul J. Silver, David J. Triggle	164
10	Comparative aspects and temperature dependence of [³H]1,4-dihydropyridine Ca²⁺ channel antagonist and activator binding to neuronal and muscle membranes 1987 ·Canadian Journal of Physiology and Pharmacology ·David Rampe, E. Luchowski, A. Rutledge, Ronald A. Janis, David J. Triggle	17
11	[3H]BAY K 8644, a 1,4-dihydropyridine Ca++ channel activator: characteristics of binding to high and low affinity sites in cardiac membranes. 1987 ·Journal of Pharmacology and Experimental Therapeutics ·J. George Sarmiento, Alka Shrikhande, Ronald A. Janis, D. J. Triggle	20
12	Photoaffinity labelling of a 33–35,000 dalton protein in cardiac, skeletal and smooth muscle membranes using a new 125I-labelled 1,4-dihydropyridine calcium channel antagonist 1986 ·Life Sciences ·J. George Sarmiento, Paul M. Epstein, William A. Rowe, David W. Chester, Henry M. Smilowitz, E Wehinger, Ronald A. Janis	6
13	Effects of metal cations and calmodulin antagonists on [3H] nitrendipine binding in smooth and cardiac muscle. 1984 ·Journal of Pharmacology and Experimental Therapeutics ·E. Luchowski, Fouad Yousif, D. J. Triggle, (unknown), J. George Sarmiento, Ronald A. Janis	65
14	BAY K 8644, a 1,4‐Dihydropyridine Ca²⁺ Channel Activator: Dissociation of Binding and Functional Effects in Brain Synaptosomes 1984 ·Journal of Neurochemistry ·David Rampe, Ronald A. Janis, David J. Triggle	87
15	Comparison of high affinity binding of calcium channel blocking drugs to vascular smooth muscle and cardiac sarcolemmal membranes 1984 ·Biochemical Pharmacology ·J. George Sarmiento, Ronald A. Janis, Arnold M. Katz, David J. Triggle	27
16	EFFECTS OF HYDRALAZINE AND VERAPAMIL ON PHOSPHORYLASE ACTIVITY AND GUANOSINE CYCLIC 3′,5′‐MONOPHOSPHATE LEVELS IN GUINEA‐PIG TAENIA COLI 1980 ·British Journal of Pharmacology ·Jack Diamond, Ronald A. Janis	13
17	Protein phosphorylation during spontaneous contraction of smooth muscle 1980 ·Biochemical and Biophysical Research Communications ·Ronald A. Janis, Billie M. Moats‐Staats, RJ Gualtieri	23
18	Relationship between blood pressure of spontaneously hypertensive rats and alterations in membrane properties of mesenteric arteries. 1977 ·Circulation Research ·Jiann-Wu Wei, Ronald A. Janis, E. E. Daniel	6
19	Isolation and Characterization of Plasma Membrane from Rat Mesenteric Arteries 1976 ·Journal of Vascular Research ·Jiann-Wu Wei, Ronald A. Janis, Edwin E. Daniel	30
20	Aortic Reactivity of Rats with Genetic and Experimental Renal Hypertension 1972 ·Canadian Journal of Physiology and Pharmacology ·F P Field, Ronald A. Janis, David J. Triggle	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact